Article
Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.
The Biochemical journal - 15 Dec 1998
Aoyama M, Grabowski D R, Dubyak G R, Constantinou A I, Rybicki L A, Bukowski R M, Ganapathi M K, Hickson I D, Ganapathi R
Abstract excerpt
Topoisomerase II (topo II), an essential enzyme for cell viability, is also the target for clinically important anti-neoplastic agents that stimulate topo II-mediated DNA scission. The role of alterations in topo IIalpha phosphorylation and its effect on drug-induced DNA damage and cytotoxicity w...
Topics
- Antigens, Neoplasm
- Antineoplastic Agents
- Buffers
- Calcium
- Chelating Agents
- DNA
- DNA Topoisomerases, Type II
- DNA-Binding Proteins
- Doxorubicin
- Egtazic Acid
